Trial Information

Thai Cancer Anemia Survey in Chulalongkorn Hospital

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in
an adult cancer population. This survey is not intended to interfere with standard medical
practices for handling anemia. Information on laboratory values including target and
achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron
supplementation, and epoetin will be collected in addition to information on cancer status
and treatment. Data on the level that triggers clinicians to decide on the need for anemia
therapy will also be collected. Each patient included in the survey will be followed for six
months. Observational Study - No investigational drug administered